Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

mms international health products pty ltd - aesculus hippocastanum,calendula officinalis -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

mms international health products pty ltd - serenoa repens -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

mms international health products pty ltd - hypericum perforatum,rosmarinus officinalis -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

mms international health products pty ltd - uncaria tomentosa -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - amoxicillin sodium, quantity: 1060 mg (equivalent: amoxicillin, qty 1000 mg) - injection, powder for - excipient ingredients: - fisamox is indicated in the treatment of infections due to susceptible strains of the organisms listed below. fisamox powder for injection is intended for use where the patients condition precludes the administration of the oral form. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however in emergency cases where the causative organism has not yet been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. septicaemia (bacterial) h. influenzae, e. coli (see microbiology), p. mirabilis, streptococci, s. pneumoniae, s. faecalis and salmonella typhi. skin and skin structure streptococci, non-beta-lactamase-producing staphylococci, e. coli (see microbiology). respiratory, acute and chronic h. influenzae, streptococci, s. pneumoniae, non-beta-lactamase-producing staphylococci, e. coli (see microbiology). genito-urinary tract (complicated and uncomplicated), acute and chronic e. coli (see microbiology), p. mirabilis and s. faecalis. gonorrhoea n. gonorrhoeae (non-beta-lactamase-producing) prophylaxis of endocarditis fisamox may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with prosthetic heart valves or those who have previously had endocarditis.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

mms international health products pty ltd - curcuma longa -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

mms international health products pty ltd - gymnema sylvestre -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

mms international health products pty ltd - echinacea angustifolia,echinacea purpurea -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tazobactam sodium; piperacillin sodium; piperacillin (as sodium); tazobactam (as sodium) -